Consortium for the Lifespan Examination of ADHD Registry (CLEAR) Study: An International, Longitudinal, Observational Study of Individuals with Attention-Deficit/Hyperactivity Disorder (ADHD)
Phase 4
Withdrawn
- Conditions
- hyperactivityhyperkinetic syndrome10009841
- Registration Number
- NL-OMON34203
- Lead Sponsor
- Shire
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
Patients meeting all of the criteria listed below at the time of consent may be included in the study:
1. Documented diagnosis of ADHD by a physician/clinician.
2. Age 18 years or older.
3. Read, comprehend, and speak the native language of the country in which they reside.
4. An understanding, ability, and willingness to participate in the study and comply with the requirements of the
protocol.
5. Ability to provide written, signed, and dated (personally) informed consent to participate in the study.
Exclusion Criteria
Patients are excluded from the study if any of the following criteria are met at screening/enrollment:
1. Life expectancy less than 12 months.
2. Currently enrolled in an ADHD clinical trial.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Multiple study questions, rather than hypotheses, will be addressed over the<br /><br>course of the study.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Multiple study questions, rather than hypotheses, will be addressed over the<br /><br>course of the study.</p><br>